A simulative deep learning model of SNP interactions on chromosome 19 for predicting Alzheimer's disease risk and rates of disease progression
- PMID: 37409680
- PMCID: PMC10770299
- DOI: 10.1002/alz.13319
A simulative deep learning model of SNP interactions on chromosome 19 for predicting Alzheimer's disease risk and rates of disease progression
Abstract
Background: Identifying genetic patterns that contribute to Alzheimer's disease (AD) is important not only for pre-symptomatic risk assessment but also for building personalized therapeutic strategies.
Methods: We implemented a novel simulative deep learning model to chromosome 19 genetic data from the Alzheimer's Disease Neuroimaging Initiative and the Imaging and Genetic Biomarkers of Alzheimer's Disease datasets. The model quantified the contribution of each single nucleotide polymorphism (SNP) and their epistatic impact on the likelihood of AD using the occlusion method. The top 35 AD-risk SNPs in chromosome 19 were identified, and their ability to predict the rate of AD progression was analyzed.
Results: Rs561311966 (APOC1) and rs2229918 (ERCC1/CD3EAP) were recognized as the most powerful factors influencing AD risk. The top 35 chromosome 19 AD-risk SNPs were significant predictors of AD progression.
Discussion: The model successfully estimated the contribution of AD-risk SNPs that account for AD progression at the individual level. This can help in building preventive precision medicine.
Keywords: Alzheimer's disease; deep learning; genetics.
© 2023 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
Conflicts of Interest
We have no conflicts of interest to disclose. Please refer ICMJE forms for detailed information.
References
-
- Mucke L Neuroscience: Alzheimer’s disease. Nature. 2009;461:895–7. - PubMed
-
- Wenk GL. Neuropathologic changes in Alzheimer’s disease. J Clin Psychiatry. 2003;64 Suppl 9:7–10. - PubMed
-
- 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17:327–406. - PubMed
-
- McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AG058854/AG/NIA NIH HHS/United States
- R56 AG057195/AG/NIA NIH HHS/United States
- R37 AG057739/AG/NIA NIH HHS/United States
- K23 AG062555/AG/NIA NIH HHS/United States
- U19 AG024904/AG/NIA NIH HHS/United States
- R01 AG061788/AG/NIA NIH HHS/United States
- P30 AG072976/AG/NIA NIH HHS/United States
- R01 NR018162/NR/NINR NIH HHS/United States
- R01 AG070883/AG/NIA NIH HHS/United States
- R01 AG040770/AG/NIA NIH HHS/United States
- R01 AG037639/AG/NIA NIH HHS/United States
- T32 AG071444/AG/NIA NIH HHS/United States
- RF1 NS128961/NS/NINDS NIH HHS/United States
- R01 AG019771/AG/NIA NIH HHS/United States
- R01 AI054546/AI/NIAID NIH HHS/United States
- R01 AG070931/AG/NIA NIH HHS/United States
- U01 AG072177/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- U24 AG021886/AG/NIA NIH HHS/United States
- U01 AG057195/AG/NIA NIH HHS/United States
- R42 AG069629/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- R01 ES031401/ES/NIEHS NIH HHS/United States
- U01 AG068057/AG/NIA NIH HHS/United States
- U24 NS095871/NS/NINDS NIH HHS/United States
- R21 AG072101/AG/NIA NIH HHS/United States
- P41 RR013642/RR/NCRR NIH HHS/United States
- R01 AG057739/AG/NIA NIH HHS/United States
- U01 AG057195/NH/NIH HHS/United States
- R01 AG068193/AG/NIA NIH HHS/United States
- R01 LM012535/LM/NLM NIH HHS/United States
- R61 AG066543/AG/NIA NIH HHS/United States
- R01 LM013463/LM/NLM NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous